BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Biopharma Update on the Novel Coronavirus: July 29

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 29, 2020.

  July 29, 2020

   · 

  5 min read

   · 

  BioSpace Editorial Staff
• 

  Policy

  GSK and Sanofi Strike Deal with U.K. Government for 60 Million COVID-19 Vaccine Doses

  Three months after joining forces to develop an adjuvanted vaccine for COVID-19, Sanofi and GlaxoSmithKline reached an agreement with the U.K. government to provide up to 60 million doses of the preventative medication.

  July 29, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Genentech Licenses Alzheimer’s Drug from UCB in Potential $2 Billion Deal

  The drug is an investigational monoclonal antibody being developed for tauopathies like progressive supranuclear palsy (PSP) and Alzheimer’s disease.

  July 29, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Career Advice

  6 of the Most Popular Soft Skills for Resume (And How to Show You Have Them)

  Do you have soft skills but don’t know how to show them on your resume? Here are 6 of the most popular soft skills for resume and tips on how to make sure they get noticed.

  July 29, 2020

   · 

  3 min read

   · 

  Laura Brothers
• 

  Drug Development

  Roche’s Actemra Misses the Mark in Phase III COVID-19 Associated Pneumonia Study

  Roche’s Actemra failed to meet its primary and secondary endpoints in a late-stage study involving hospitalized patients with severe COVID-19 associated pneumonia.

  July 29, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Genetown

  Omega Therapeutics Rakes in $85 Million One Year After Launch

  Omega Therapeutics has secured $85 million in financing nearly one year after the company launched to develop a new category of genomic medicine through epigenomic programming.

  July 29, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital

  Following her time as a Managing Partner at Baxter Ventures and Baxalta Ventures, Vemuri founded Agent Capital, a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs.

  July 29, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Genetown

  Moderna and NIAID Publish Positive COVID-19 Vaccine Data in Monkeys

  Moderna published data in The New England Journal of Medicine late yesterday in non-human primate studies of its MRNA-1273 vaccine against COVID-19.

  July 29, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  Thrive Brings in $257 Million More to Advance Cancer Liquid Biopsy Assay

  Thrive Earlier Detection, headquartered in Cambridge, Massachusetts, closed on a Series B financing worth $257 million.

  July 29, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  The Time for DMD Gene Therapy is Now: A Chat with the MDA

  After almost 15 years since the first gene therapy trial for Duchenne muscular dystrophy (DMD) began, the dream of a DMD gene therapy drug is getting closer to a reality.

  July 29, 2020

   · 

  11 min read

   · 

  Chelsea Weidman Burke